Difference between revisions of "Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2 (Q11014)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1592830820928) |
(Created claim: Page(s) (P105): 2605-2610, #quickstatements; #temporary_batch_1592836326594) |
||||||||||||||
| (15 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / title | |||||||||||||||
| + | Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 (English) | ||||||||||||||
| Property / title: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2005
| ||||||||||||||
| Property / Publication Date: 2005 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / First Author string | |||||||||||||||
| + | Ferrario CM | ||||||||||||||
| Property / First Author string: Ferrario CM / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Jessup J | ||||||||||||||
| Property / Second Author string: Jessup J / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Chappell MC | ||||||||||||||
| Property / Third Author string: Chappell MC / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fourth Author string | |||||||||||||||
| + | Averill DB | ||||||||||||||
| Property / Fourth Author string: Averill DB / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fifth Author string | |||||||||||||||
| + | Brosnihan KB | ||||||||||||||
| Property / Fifth Author string: Brosnihan KB / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Sixth Author string | |||||||||||||||
| + | Tallant EA | ||||||||||||||
| Property / Sixth Author string: Tallant EA / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Seventh Author string | |||||||||||||||
| + | Diz DI | ||||||||||||||
| Property / Seventh Author string: Diz DI / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Eighth Author string | |||||||||||||||
| + | Gallagher PE | ||||||||||||||
| Property / Eighth Author string: Gallagher PE / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Circulation | ||||||||||||||
| Property / Published In Name String: Circulation / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1161/CIRCULATIONAHA.104.510461 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 15897343 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 111 | ||||||||||||||
| Property / Volume: 111 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 2605-2610 | ||||||||||||||
| Property / Page(s): 2605-2610 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| links / sliswiki / name | links / sliswiki / name | ||||||||||||||
| + | |||||||||||||||
Latest revision as of 14:32, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 (English)
0 references
2005
0 references
Ferrario CM
0 references
Jessup J
0 references
Chappell MC
0 references
Averill DB
0 references
Brosnihan KB
0 references
Tallant EA
0 references
Diz DI
0 references
Gallagher PE
0 references
Circulation
0 references
111
0 references
2605-2610
0 references